Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sumitomo Dainippon Pharma Co Ltd (JP:4506)
TSE/TYO:4506
Holding JP:4506?
Track your performance easily
4506 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥279.00 - ¥680.00
Previous Close¥675
Volume12.78M
Average Volume (3M)4.55M
Market Cap
¥268.17B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.36
Next Earnings
Oct 28, 2024EPS Estimate
-¥44.18Last Dividend Ex-Date
Mar 30, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-654.85
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume4,553,777
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥443.22Price Target Upside-34.34% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering3
Sumitomo Dainippon Pharma Co News
PremiumCompany Announcements
Sumitomo Pharma Initiates Early Retirement Program
PremiumCompany Announcements
Sumitomo Pharma Records Robust Q1 Finance Income
PremiumCompany Announcements
Sumitomo Dainippon Pharma Projects Q1 FY2024 Outlook
PremiumCompany Announcements
Sumitomo Pharma Reports Profit and Revenue GrowthPremiumCompany Announcements
Sumitomo Pharma Reports Strong Q1 Revenue Growth
PremiumCompany Announcements
Sumitomo Pharma Advances Corporate GovernanceOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.05% Mutual Funds
2.64% Other Institutional Investors
96.31% Public Companies and
Individual Investors
4506 FAQ
What was Sumitomo Dainippon Pharma Co Ltd’s price range in the past 12 months?
Sumitomo Dainippon Pharma Co Ltd lowest stock price was ¥279.00 and its highest was ¥680.00 in the past 12 months.
What is Sumitomo Dainippon Pharma Co Ltd’s market cap?
Currently, no data Available
When is Sumitomo Dainippon Pharma Co Ltd’s upcoming earnings report date?
Sumitomo Dainippon Pharma Co Ltd’s upcoming earnings report date is Oct 28, 2024 which is in 64 days.
How were Sumitomo Dainippon Pharma Co Ltd’s earnings last quarter?
Sumitomo Dainippon Pharma Co Ltd released its earnings results on Jul 31, 2024. The company reported ¥40.11 earnings per share for the quarter, beating the consensus estimate of -¥10.564 by ¥50.674.
Is Sumitomo Dainippon Pharma Co Ltd overvalued?
According to Wall Street analysts Sumitomo Dainippon Pharma Co Ltd’s price is currently Overvalued.
Does Sumitomo Dainippon Pharma Co Ltd pay dividends?
Sumitomo Dainippon Pharma Co Ltd pays a Annually dividend of ¥7 which represents an annual dividend yield of N/A. See more information on Sumitomo Dainippon Pharma Co Ltd dividends here
What is Sumitomo Dainippon Pharma Co Ltd’s EPS estimate?
Sumitomo Dainippon Pharma Co Ltd’s EPS estimate is -¥44.18.
How many shares outstanding does Sumitomo Dainippon Pharma Co Ltd have?
Sumitomo Dainippon Pharma Co Ltd has 397,900,150 shares outstanding.
What happened to Sumitomo Dainippon Pharma Co Ltd’s price movement after its last earnings report?
Sumitomo Dainippon Pharma Co Ltd reported an EPS of ¥40.11 in its last earnings report, beating expectations of -¥10.564. Following the earnings report the stock price went down -1.182%.
Which hedge fund is a major shareholder of Sumitomo Dainippon Pharma Co Ltd?
Currently, no hedge funds are holding shares in JP:4506
---
Sumitomo Dainippon Pharma Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.97%
12-Months-Change
Fundamentals
Return on Equity
-90.80%
Trailing 12-Months
Asset Growth
-31.56%
Trailing 12-Months
Company Description
Sumitomo Dainippon Pharma Co Ltd
Sumitomo Dainippon Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
---
4506 Stock 12 Month Forecast
Average Price Target
¥443.22
▼(-34.34% Downside)
Technical Analysis
Moderna
―
AstraZeneca
―
Takeda Pharmaceutical Company
―
Bristol-Myers Squibb
―
Sumitomo Dainippon Pharma Co
―
Best Analysts Covering 4506
1 Year
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
downgraded a sell rating last month
Copying Kasumi Haruta's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
---